SEC Form 4 · accession 0001209191-19-017877
Fulgent Genetics, Inc. · FLGT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ming Hsieh
Officer — President and CEO · Director · 10% Owner
Period of report
Mar 5, 2019
Accepted (ET)
Mar 7, 2019 · 7:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001674930
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 5, 2019 | P | 8,739 | $4.9479 | A | 6,579,326 | D | |
| Common StockF2 | holding | — | — | — | 1,315,789 | I | by Annuity Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were purchased in multiple transactions at prices ranging from $4.85 to $4.95, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F2The securities are held of record by the Ming Hsieh Annuity Trust established May 4, 2016, over which the reporting person possesses sole voting and dispositive power as the sole trustee.